Sab Biotherapeutics Inc. (SABS)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
2. 53
-0.06
-2.3166%
$
271.14M Market Cap
0.1 P/E Ratio
- Div Yield
756,767 Volume
0 Eps
$ 2.59
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
SAB Biotherapeutics (SABS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 1 year ago
2026 © Marketlog. All Rights Reserved.
